1-3 of 3
Chiaki Nakaseko, M.D., PhD.
Close
Sort by
Journal Articles

LR11 Is a Novel Surface Marker for Normal Leukocytes and Leukemia Cells

Masahiro Takeuchi, M.D., PhD., Chikako Ohwada, M.D., PhD., Shio Sakai, M.D., Yusuke Takeda, M.D., PhD., Daijiro Abe, M.D., PhD., Naomi Shimizu, M.D., PhD., Emiko Sakaida, M.D., PhD., Takeharu Kawaguchi, M.D., Kohei Takubo, PhD., Hiroyuki Ebinuma, PhD., Isamu Fukamachi, PhD., Koutaro Yokote, M.D., PhD., Atsushi Iwama, M.D., PhD., Wolfgang J Schneider, PhD., Hideaki Bujo, M.D., PhD., Chiaki Nakaseko, M.D., PhD.
Journal: Blood
Blood (2010) 116 (21): 4834.
https://doi.org/10.1182/blood.V116.21.4834.4834
Published: 2010
Journal Articles

Direct Activation of STAT5 by TEL-Lyn Fusion Protein Promotes Induction of Myeloproliferative Neoplasms with Myelofibrosis

Yusuke Takeda, M.D., PhD., Chiaki Nakaseko, M.D., PhD., Hiroaki Tanaka, M.D., PhD., Masahiro Takeuchi, M.D., PhD., Makiko Yui, Atsunori Saraya, Satoru Miyagi, PhD., Chikako Ohwada, M.D., PhD., Emiko Sakaida, M.D., PhD., Koutaro Yokote, M.D., PhD., Atsushi Iwama, M.D., PhD.
Journal: Blood
Blood (2010) 116 (21): 4114.
https://doi.org/10.1182/blood.V116.21.4114.4114
Published: 2010
Journal Articles

Prognostic Impact of a Novel Biomarker, Serum Soluble LR11 on Acute Leukemia

Chikako Ohwada, M.D., PhD., Masahiro Takeuchi, M.D., PhD., Shio Sakai, M.D., Daijiro Abe, M.D., PhD., Yusuke Takeda, M.D., PhD., Naomi Shimizu, M.D., PhD., Emiko Sakaida, M.D., PhD., Takeharu Kawaguchi, M.D., Kohei Takubo, PhD., Hiroyuki Ebinuma, PhD., Isamu Fukamachi, PhD., Koutaro Yokote, M.D., PhD., Atsushi Iwama, M.D., PhD., Wolfgang J Schneider, PhD, Hideaki Bujo, M.D., PhD., Chiaki Nakaseko, M.D., PhD.
Journal: Blood
Blood (2010) 116 (21): 2717.
https://doi.org/10.1182/blood.V116.21.2717.2717
Published: 2010